EUVIMEDEUVIMED entdecken
ValidierungsstudieVergleichsstudieOpen Access · CC BY-NC 4.0

Validation of the Atopic Dermatitis Control Tool (ADCT) and a Comparison with the Recap of Atopic Eczema Questionnaire (RECAP)

Junfen Zhang, Leon Miltner, Laura Loman, Aviël Ragamin, Jart A F Oosterhaven, Marie L A Schuttelaar

Acta Dermato-Venereologica · 18.02.2025 · 105 · adv42364

DOI: 10.2340/actadv.v105.42364 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 18.02.2025. Verfasst von Junfen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Hospital, Southern Medical University, Guangzhou, China; Department of Dermatology, University of Groningen, University Medical Center Gr…. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Atopic Dermatitis Control Tool (ADCT) has not been validated in the Dutch population, and comparisons with the Recap of atopic eczema (RECAP) questionnaire are still lacking. This prospective study was conducted at a Dutch tertiary hospital between June 2021 and December 2022, to assess measurement properties of the Dutch ADCT in adults with atopic dermatitis (AD) and compare it with RECAP. Participants completed the ADCT, RECAP, and reference instruments including Patient’s Global Assessment (PtGA), Patient-Oriented Eczema Measure (POEM), Dermatology Life Quality Index (DLQI), quality-of-life questionnaire of the EuroQol Group (EQ-5D-5L), Numeric Rating Scale (NRS) peak itch/sleep disturbance, Skindex-29, and Global Rating of Change (GRC), at baseline, 1–3 days, and 4–12 weeks. Construct validity was assessed through a priori hypotheses, whilst reliability was evaluated with standard error of measurement (SEMagreement) and intraclass correlation coefficient (ICCagreement). Interpretability was examined using anchor-based approaches. In total, 196 adults with AD were included. Among a priori hypotheses, 82% (single-score validity) and 59% (responsiveness) were confirmed. The SEMagreement was 1.15, and the ICCagreement was 0.983. The final bandings for the ADCT were established, with a binary cutoff of ≥ 6 indicating uncontrolled AD. The smallest detectable change (SDC) was 3.2, and the minimally important change (MIC) value from predictive modelling was 2.9. Furthermore, the ADCT exhibited high correlations with RECAP at all levels (most correlations being above 0.80). These results demonstrated the Dutch ADCT as a valid, reliable, and responsive tool, and have important clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansMaleFemaleAdultProspective StudiesMiddle AgedReproducibility of ResultsQuality of LifeSurveys and QuestionnairesNetherlandsSeverity of Illness IndexYoung AdultPredictive Value of Tests

Autor:innen und Institutionen

  • Dermatology Hospital, Southern Medical University, Guangzhou, China; Department of Dermatology, University of Groningen, University Medical Center Groningen, the Netherlands. jzhang01@smu.edu.cn.
  • Department of Dermatology, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Dermatology, University of Groningen, University Medical Center Groningen, the Netherlands. m.l.a.schuttelaar@umcg.nl.

Zitieren

APA

Zhang, J., Miltner, L., Loman, L., Ragamin, A., Oosterhaven, J. A. F., & Schuttelaar, M. L. A. (2025). Validation of the Atopic Dermatitis Control Tool (ADCT) and a Comparison with the Recap of Atopic Eczema Questionnaire (RECAP). Acta Dermato-Venereologica, 105, adv42364. https://doi.org/10.2340/actadv.v105.42364

Vancouver

Zhang J, Miltner L, Loman L, Ragamin A, Oosterhaven JAF, Schuttelaar MLA. Validation of the Atopic Dermatitis Control Tool (ADCT) and a Comparison with the Recap of Atopic Eczema Questionnaire (RECAP). Acta Dermato-Venereologica. 2025;105:adv42364. doi:10.2340/actadv.v105.42364

BibTeX
@article{Zhang2025,
  author = {Zhang, Junfen and Miltner, Leon and Loman, Laura and Ragamin, Aviël and Oosterhaven, Jart A F and Schuttelaar, Marie L A},
  title = {Validation of the Atopic Dermatitis Control Tool (ADCT) and a Comparison with the Recap of Atopic Eczema Questionnaire (RECAP)},
  journal = {Acta Dermato-Venereologica},
  year = {2025},
  volume = {105},
  pages = {adv42364},
  doi = {10.2340/actadv.v105.42364}
}
Kostenlos starten →